The TGA consulted with the public on the draft Guidelines for the quality of listed probiotic medicines (now known as ‘Demonstrating the Quality of Listed Probiotic Medicines’). The purpose of this consultation was to seek stakeholder feedback on the clarity and presentation of information before publication. The feedback has been used to improve how the information is conveyed and the overall readability of the Guidelines.
Outcomes of consultation
We received 14 responses to this consultation. We published a summary of the responses, including those individual responses where the respondent consented to publication, on our TGA consultation hub.
